{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:29:31Z","timestamp":1781332171315,"version":"3.54.1"},"reference-count":106,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>The \u201cvanishing bone disease\u201d or Gorham-Stout disease (GSD) is a very rare disorder characterized by massive lymphatic and angiomatous proliferation accompanied by progressive osteolysis, without the deposition of new bone matrix. Because of its rare and complex clinical features, diagnosis is challenging and its etiopathogenesis is not completely known; the genetic basis of GSD has been hypothesized and different mutations have been reported in patients. Our review aims to describe all these genetic alterations found in GSD patients and their association with clinical features. The identification of a specific molecular pathway or genetic alteration in GSD could help in the diagnosis and possibly the treatment of this rare sporadic disease.<\/jats:p>","DOI":"10.3389\/fendo.2025.1654497","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T04:10:26Z","timestamp":1755576626000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Exploring the genetic alterations of Gorham-Stout disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Olivia","family":"Pagliarosi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Del Fattore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13023-025-03649-9","article-title":"Clinical features and current management experience in Gorham-Stout disease: a systematic review","volume":"20","author":"Zhou","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bone.2014.02.011","article-title":"Viewpoints on vessels and vanishing bones in Gorham-Stout disease","volume":"63","author":"Dellinger","year":"2014","journal-title":"Bone"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.5312\/wjo.v5.i5.694","article-title":"Vanishing bone disease (Gorham-Stout syndrome): A review of a rare entity","volume":"5","author":"Nikolaou","year":"2014","journal-title":"World J Orthop"},{"key":"B4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.humpath.2007.04.022","article-title":"Lymphatics and bone","volume":"39","author":"Edwards","year":"2008","journal-title":"Hum Pathol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1378\/chest.105.1.208","article-title":"Chylothorax in Gorham\u2019s syndrome. A common complication of a rare disease","volume":"105","author":"Tie","year":"1994","journal-title":"Chest"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e30219","DOI":"10.1002\/pbc.30219","article-title":"Kaposiform lymphangiomatosis: Diagnosis, pathogenesis, and treatment","volume":"70","author":"McDaniel","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1089\/wound.2018.0850","article-title":"Generalized lymphatic anomaly and gorham-stout disease: overview and recent insights","volume":"8","author":"Ozeki","year":"2019","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1631\/jzus.B1200308","article-title":"Gorham-Stout syndrome in mainland China: a case series of 67 patients and review of the literature","volume":"14","author":"Hu","year":"2013","journal-title":"J Zhejiang Univ Sci B"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-012-1565-4","article-title":"Gorham-Stout disease and generalized lymphatic anomaly\u2013clinical, radiologic, and histologic differentiation","volume":"42","author":"Lala","year":"2013","journal-title":"Skeletal Radiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.21037\/qims-24-1252","article-title":"Clinical and CT imaging features of different types of thoracic complex lymphatic anomaly","volume":"15","author":"Zhang","year":"2025","journal-title":"Quant Imaging Med Surg"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/bonekey.2013.210","article-title":"First international conference on generalized lymphatic anomaly and gorham-stout syndrome","author":"Dellinger MT","year":"2013","journal-title":"IBMS BoneKEy"},{"key":"B12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2106\/00004623-197759010-00009","article-title":"Disappearing bone disease","volume":"59","author":"Heyden","year":"1977","journal-title":"A Clin Histol Study J Bone Joint Surg Am"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/8756-3282(90)90215-K","article-title":"An investigation of vanishing bone disease","volume":"11","author":"Dickson","year":"1990","journal-title":"Bone"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.81.5.8626854","article-title":"Interleukin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout disease","volume":"81","author":"Devlin","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34323","article-title":"VEGF-C promotes the development of lymphatics in bone and bone loss","volume":"7","author":"Hominick","year":"2018","journal-title":"Elife"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2008.06.005","article-title":"VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and beta3-integrin","volume":"27","author":"Yang","year":"2008","journal-title":"Matrix Biol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1018501108","article-title":"TNF-alpha promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells","volume":"108","author":"Glass","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI82585","article-title":"Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair","volume":"126","author":"Hu","year":"2016","journal-title":"J Clin Invest"},{"key":"B19","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/adj.12752","article-title":"The in vitro effect of VEGF receptor inhibition on primary alveolar osteoblast nodule formation","volume":"65","author":"McLaughlin","year":"2020","journal-title":"Aust Dent J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"115068","DOI":"10.1016\/j.bone.2019.115068","article-title":"Dissecting the mechanisms of bone loss in Gorham-Stout disease","volume":"130","author":"Rossi","year":"2020","journal-title":"Bone"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-024-02365-8","article-title":"Analysis of circulating osteoclast and osteogenic precursors in patients with Gorham-Stout disease","volume":"47","author":"Rossi","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.706596","article-title":"Stimulation of treg cells to inhibit osteoclastogenesis in gorham-stout disease","volume":"9","author":"Rossi","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2009.08.045","article-title":"Conservative treatment of a pathologic fracture in a patient with Gorham-Stout disease","volume":"109","author":"Pedroletti","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24832","article-title":"Novel molecular pathways in Gorham disease: implications for treatment","volume":"61","author":"Hagendoorn","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200310000-00016","article-title":"Radiation therapy in the treatment of Gorham disease","volume":"25","author":"Fontanesi","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(93)90968-2","article-title":"Gorham\u2019s massive osteolysis: the role of radiation therapy and a review of the literature","volume":"26","author":"Dunbar","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.01.006","article-title":"Radiation therapy for Gorham-Stout syndrome: results of a national patterns-of-care study and literature review","volume":"81","author":"Heyd","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3121\/cmr.3.2.83","article-title":"A case of Gorham\u2019s disease with chylothorax treated curatively with radiation therapy","volume":"3","author":"Duffy","year":"2005","journal-title":"Clin Med Res"},{"key":"B29","article-title":"Late effects of abdominal irradiation in children: a review of the literature","volume":"30","author":"Bolling","year":"2010","journal-title":"Anticancer Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2780-2","article-title":"Gorham-Stout disease: radiological, histological, and clinical features of 12 cases and review of literature","volume":"35","author":"Liu","year":"2016","journal-title":"Clin Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.041113","article-title":"Gorham-Stout disease\u2013stabilization during bisphosphonate treatment","volume":"20","author":"Hammer","year":"2005","journal-title":"J Bone Miner Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.71","article-title":"Short-term and long-term effects of osteoporosis therapies","volume":"11","author":"Reid","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)63639-2","article-title":"Alpha-2b interferon and oral clodronate for Gorham\u2019s disease","volume":"350","author":"Hagberg","year":"1997","journal-title":"Lancet"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.20849","article-title":"Gorham-Stout Syndrome with chylothorax: successful remission by interferon alpha-2b","volume":"44","author":"Kose","year":"2009","journal-title":"Pediatr Pulmonol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2004.11.015","article-title":"Remission induced by interferon alfa in a patient with massive osteolysis and extension of lymph-hemangiomatosis: a severe case of Gorham-Stout syndrome","volume":"40","author":"Takahashi","year":"2005","journal-title":"J Pediatr Surg"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e3181edb464","article-title":"Treatment of Gorham-Stout disease with zoledronic acid and interferon-alpha: a case report and literature review","volume":"32","author":"Kuriyama","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq331","article-title":"First report of effective and feasible treatment of multifocal lymphangiomatosis (Gorham-Stout) with bevacizumab in a child","volume":"21","author":"Grunewald","year":"2010","journal-title":"Ann Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.22869","article-title":"Propranolol as a treatment option in Gorham-Stout syndrome: a case report","volume":"49","author":"Nir","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2011.02361.x","article-title":"A novel treatment approach for paediatric Gorham-Stout syndrome with chylothorax","volume":"100","author":"Brodszki","year":"2011","journal-title":"Acta Paediatr"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e31441","DOI":"10.1002\/pbc.31441","article-title":"Effective use of ALK inhibitors in EML4::ALK-positive lymphatic malformations","volume":"72","author":"Apsel Winger","year":"2025","journal-title":"Pediatr Blood Cancer"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e27614","DOI":"10.1002\/pbc.27614","article-title":"Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham-Stout disease","volume":"66","author":"Ricci","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.35406","article-title":"PTEN hamartoma tumor syndrome and Gorham-Stout phenomenon","author":"Hopman","year":"2012","journal-title":"Am J Med Genet A"},{"key":"B43","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ajhg.2010.11.013","article-title":"A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands","volume":"88","author":"Tan","year":"2011","journal-title":"Am J Hum Genet"},{"key":"B44","article-title":"Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological Malignancies","volume":"57","author":"Tashiro","year":"1997","journal-title":"Cancer Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0","article-title":"Mutations of the human PTEN gene","volume":"16","author":"Bonneau","year":"2000","journal-title":"Hum Mutat"},{"key":"B46","article-title":"PTEN gene mutations are seen in high-grade but not in low-grade gliomas","volume":"57","author":"Rasheed","year":"1997","journal-title":"Cancer Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-10-1089","article-title":"PI3K pathway mutations and PTEN levels in primary and metastatic breast cancer","volume":"10","author":"Gonzalez-Angulo","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203801","article-title":"Expression of PTEN in PTEN-deficient multiple myeloma cells abolishes tumor growth in vivo","volume":"19","author":"Ge","year":"2000","journal-title":"Oncogene"},{"key":"B49","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V96.10.3560","article-title":"Loss of PTEN expression leading to high Akt activation in human multiple myelomas","volume":"96","author":"Hyun","year":"2000","journal-title":"Blood"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.03.003","article-title":"Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma","volume":"7","author":"Chen","year":"2014","journal-title":"Cell Rep"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23782","article-title":"Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors","volume":"113","author":"Freeman","year":"2008","journal-title":"Cancer"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jos.2024.10.016","article-title":"Analysis of cancer multigene panel testing for osteosarcoma in pediatric and adults using the center for cancer genomics and advanced therapeutics database in Japan","author":"Suehara","year":"2024","journal-title":"J Orthop Sci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.25159","article-title":"Oncogenic and therapeutic targeting of PTEN loss in bone Malignancies","volume":"116","author":"Xi","year":"2015","journal-title":"J Cell Biochem"},{"key":"B54","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0092-8674(00)81780-8","article-title":"Negative regulation of PKB\/Akt-dependent cell survival by the tumor suppressor PTEN","volume":"95","author":"Stambolic","year":"1998","journal-title":"Cell"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/S0898-6568(01)00271-6","article-title":"The protein kinase B\/Akt signalling pathway in\u00a0human Malignancy","volume":"14","author":"Nicholson","year":"2002","journal-title":"Cell Signal"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20181353","article-title":"Somatic activating mutations in PIK3CA cause generalized lymphatic anomaly","volume":"216","author":"Rodriguez-Laguna","year":"2019","journal-title":"J\u00a0Exp Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M209299200","article-title":"PTEN regulates RANKL- and osteopontin-stimulated signal transduction during osteoclast differentiation and cell motility","volume":"278","author":"Sugatani","year":"2003","journal-title":"J Biol Chem"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1093\/jbmrpl\/ziad016","article-title":"Pten knockout in mouse preosteoblasts leads to changes in bone turnover and strength","volume":"8","author":"Lorenz","year":"2024","journal-title":"JBMR Plus"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14010038","article-title":"mTOR pathway substrates present high activation in vascular malformations and significantly decrease with age","volume":"14","author":"Kopec","year":"2023","journal-title":"Diagn (Basel)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3257","article-title":"Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies","volume":"137","author":"Adams","year":"2016","journal-title":"Pediatrics"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/s41372-024-01868-9","article-title":"Sirolimus for vascular anomalies in the first year of life: a systematic review","volume":"44","author":"Cavazos","year":"2024","journal-title":"J Perinatol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.22541\/au.168076669.98356508\/v1","article-title":"EML4::ALK fusions in complex lymphatic malformations","volume":"70","author":"Apsel Winger","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2012.02327.x","article-title":"Echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase-targeted therapy for advanced non-small cell lung cancer: molecular and clinical aspects","volume":"103","author":"Okamoto","year":"2012","journal-title":"Cancer Sci"},{"key":"B64","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3892\/ol.2022.13397","article-title":"EML4-ALK fusion gene in non-small cell lung cancer","volume":"24","author":"Lei","year":"2022","journal-title":"Oncol Lett"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/nature05945","article-title":"Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer","volume":"448","author":"Soda","year":"2007","journal-title":"Nature"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-6158","article-title":"Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer","volume":"68","author":"Choi","year":"2008","journal-title":"Cancer Res"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.5397-25","article-title":"A prompt diagnosis of ascites and dramatic effect of alectinib for advanced lung adenocarcinoma harboring EML4-ALK fusion: A case report","author":"Baba","year":"2025","journal-title":"Intern Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2016.09.09","article-title":"Systemic therapy for echinoderm microtubule-associated protein-like 4 anaplastic lymphoma kinase non-small cell lung cancer brain metastases","volume":"8","author":"Guo","year":"2016","journal-title":"J Thorac Dis"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2011.01970.x","article-title":"Favorable response to crizotinib in three patients with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion-type oncogene-positive non-small cell lung cancer","volume":"102","author":"Kijima","year":"2011","journal-title":"Cancer Sci"},{"key":"B70","doi-asserted-by":"publisher","first-page":"108490","DOI":"10.1016\/j.lungcan.2025.108490","article-title":"Novel strategies for rare oncogenic drivers in non-small-cell lung cancer: An update from the 2024 Annual ESMO meeting","volume":"204","author":"van der Wel","year":"2025","journal-title":"Lung Cancer"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-019-03174-1","article-title":"Cardiac tamponade in gorham-stout syndrome associated with GATA2 mutation","volume":"87","author":"Oguz","year":"2020","journal-title":"Indian J Pediatr"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002953","article-title":"Human GATA2 mutations and hematologic disease: how many paths to pathogenesis","volume":"4","author":"Bresnick","year":"2020","journal-title":"Blood Adv"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1242\/dev.184218","article-title":"GATA2 controls lymphatic endothelial cell junctional integrity and lymphovenous valve morphogenesis through miR-126","volume":"146","author":"Mahamud","year":"2019","journal-title":"Development"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/jb\/mvad122","article-title":"Perturbed collagen metabolism underlies lymphatic recanalization failure in Gata2 heterozygous deficient mice","volume":"175","author":"Watanabe-Asaka","year":"2024","journal-title":"J Biochem"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1111\/gtc.12852","article-title":"GATA2 participates in the recanalization of lymphatic vessels after surgical lymph node extirpation","volume":"26","author":"Watanabe-Asaka","year":"2021","journal-title":"Genes Cells"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00599-17","article-title":"Loss of the hematopoietic stem cell factor GATA2 in the osteogenic lineage impairs trabecularization and mechanical strength of bone","volume":"38","author":"Tolkachov","year":"2018","journal-title":"Mol Cell Biol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/s10038-020-0794-y","article-title":"A somatic activating KRAS variant identified in an affected lesion of a patient with Gorham-Stout disease","volume":"65","author":"Nozawa","year":"2020","journal-title":"J Hum Genet"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2017.08.006","article-title":"KRAS alleles: the devil is in the detail","volume":"3","author":"Haigis","year":"2017","journal-title":"Trends Cancer"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/jhg.2015.114","article-title":"Recent advances in RASopathies","volume":"61","author":"Aoki","year":"2016","journal-title":"J Hum Genet"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1101\/2025.01.27.635141","article-title":"Accurate characterization of the allosteric energy landscapes, binding hotspots and long-range communications for KRAS complexes with effector proteins: integrative approach using microsecond molecular dynamics, deep mutational scanning of binding energetics and allosteric network modeling","author":"Xiao","year":"2025","journal-title":"bioRxiv"},{"key":"B81","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.semcancer.2019.06.007","article-title":"RAS mutations in human cancers: Roles in precision medicine","volume":"59","author":"Murugan","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-2612","article-title":"A comprehensive survey of Ras mutations in cancer","volume":"72","author":"Prior","year":"2012","journal-title":"Cancer Res"},{"key":"B83","article-title":"Mutant ras oncogenes upregulate VEGF\/VPF expression: implications for induction and inhibition of tumor angiogenesis","volume":"55","author":"Rak","year":"1995","journal-title":"Cancer Res"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1549407","article-title":"Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis","volume":"21","author":"Ancrile","year":"2007","journal-title":"Genes Dev"},{"key":"B85","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1158\/0008-5472.CAN-17-2084","article-title":"KRAS oncogenic signaling extends beyond cancer cells to orchestrate the microenvironment","volume":"78","author":"Dias Carvalho","year":"2018","journal-title":"Cancer Res"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-016-8594-z","article-title":"Gorham-stout disease: a clinical case report and immunological mechanisms in bone erosion","volume":"52","author":"Franco-Barrera","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.149831","article-title":"KRAS-driven model of Gorham-Stout disease effectively treated with trametinib","volume":"6","author":"Homayun-Sepehr","year":"2021","journal-title":"JCI Insight"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000002112","article-title":"Malignant giant cell tumor of bone with a KRAS G12V mutation","volume":"44","author":"Donigian","year":"2022","journal-title":"J Pediatr Hematol Oncol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e10784","DOI":"10.1002\/jbm4.10784","article-title":"Identification of a biallelic missense variant in gasdermin D (c.823G > C, p.Asp275His) in a patient of atypical gorham-stout disease in a consanguineous family","volume":"7","author":"Uehara","year":"2023","journal-title":"JBMR Plus"},{"key":"B90","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s41573-021-00154-z","article-title":"Channelling inflammation: gasdermins in physiology and disease","volume":"20","author":"Liu","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.893912","article-title":"The regulation and modification of GSDMD signaling in diseases","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.752546","article-title":"NLRP3 inflammasome: A new target for prevention and control of osteoporosis","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.548812","article-title":"Pyroptosis in osteoblasts: A novel hypothesis underlying the pathogenesis of osteoporosis","volume":"11","author":"Tao","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/nature18629","article-title":"Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores","volume":"535","author":"Liu","year":"2016","journal-title":"Nature"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"B96","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12920-022-01277-x","article-title":"Gorham-Stout case report: a multi-omic analysis reveals recurrent fusions as new potential drivers of the disease","volume":"15","author":"Yebenes Mayordomo","year":"2022","journal-title":"BMC Med Genomics"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1111\/os.12390","article-title":"Successful management of gorham-stout disease in scapula and ribs: A case report and literature review","volume":"10","author":"Li","year":"2018","journal-title":"Orthop Surg"},{"key":"B98","doi-asserted-by":"publisher","first-page":"ziae179","DOI":"10.1093\/jbmrpl\/ziae179","article-title":"Paradoxical combination of osteosclerosis and osteopenia in an adult woman with biallelic TNFRSF11A loss-of-function variants escaping nonsense-mediated decay","volume":"9","author":"Gajewski","year":"2025","journal-title":"JBMR Plus"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/71667","article-title":"Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis","volume":"24","author":"Hughes","year":"2000","journal-title":"Nat Genet"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.4161\/auto.5.7.9296","article-title":"Atg101, a novel mammalian autophagy protein interacting with Atg13","volume":"5","author":"Hosokawa","year":"2009","journal-title":"Autophagy"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.4161\/auto.5.5.8249","article-title":"A novel, human Atg13 binding protein, Atg101, interacts with ULK1 and is essential for macroautophagy","volume":"5","author":"Mercer","year":"2009","journal-title":"Autophagy"},{"key":"B102","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13395-017-0131-0","article-title":"Exome sequencing reveals independent SGCD deletions causing limb girdle muscular dystrophy in Boston terriers","volume":"7","author":"Cox","year":"2017","journal-title":"Skelet Muscle"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2018.00727","article-title":"SGCD homozygous nonsense mutation (p.Arg97(*)) causing limb-girdle muscular dystrophy type 2F (LGMD2F) in a consanguineous family, a case report","volume":"9","author":"Younus","year":"2018","journal-title":"Front Genet"},{"key":"B104","doi-asserted-by":"publisher","first-page":"3","DOI":"10.12703\/r\/12-3","article-title":"Vascular therapy for Duchenne muscular dystrophy (DMD)","volume":"12","author":"Thapa","year":"2023","journal-title":"Fac Rev"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2011.00051","article-title":"PI3K\/AKT\/mTOR pathway in angiogenesis","volume":"4","author":"Karar","year":"2011","journal-title":"Front Mol Neurosci"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.10271","article-title":"Mechanisms of VEGF (Vascular endothelial growth factor) inhibitor-associated hypertension and vascular disease","volume":"71","author":"Pandey","year":"2018","journal-title":"Hypertension"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1654497\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T04:10:28Z","timestamp":1755576628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1654497\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":106,"alternative-id":["10.3389\/fendo.2025.1654497"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1654497","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"article-number":"1654497"}}